Robbins Andrew R 4
4 · Harpoon Therapeutics, Inc. · Filed Jun 23, 2023
Insider Transaction Report
Form 4
Robbins Andrews R
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2023-06-22+23,000→ 23,000 totalExercise: $0.67Exp: 2033-06-21→ Common Stock (23,000 underlying)
Footnotes (1)
- [F1]The stock option will fully vest and become exercisable on June 21, 2024, subject to the continuous service of the Reporting Person with the Issuer on such date.